InflaRx NV (IFRX)
1.11
-0.04
(-3.48%)
USD |
NASDAQ |
Nov 18, 16:00
1.10
-0.01
(-0.90%)
After-Hours: 20:00
InflaRx Total Liabilities (Quarterly) : 19.55M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 19.55M |
| June 30, 2026 | 23.69M |
| March 31, 2026 | 13.83M |
| September 30, 2025 | 23.25M |
| June 30, 2025 | 19.25M |
| March 31, 2025 | 17.86M |
| September 30, 2024 | 16.08M |
| June 30, 2024 | 11.66M |
| March 31, 2024 | 13.32M |
| December 31, 2023 | 19.47M |
| September 30, 2023 | 12.17M |
| June 30, 2023 | 9.076M |
| March 31, 2023 | 8.400M |
| December 31, 2022 | 15.00M |
| September 30, 2022 | 11.44M |
| June 30, 2022 | 13.07M |
| March 31, 2022 | 22.21M |
| December 31, 2021 | 22.58M |
| Date | Value |
|---|---|
| September 30, 2021 | 16.39M |
| June 30, 2021 | 13.54M |
| March 31, 2021 | 9.871M |
| December 31, 2020 | 12.67M |
| September 30, 2020 | 13.63M |
| June 30, 2020 | 14.32M |
| March 31, 2020 | 13.16M |
| December 31, 2019 | 16.20M |
| September 30, 2019 | 20.02M |
| June 30, 2019 | 15.99M |
| March 31, 2019 | 10.08M |
| December 31, 2018 | 8.931M |
| September 30, 2018 | 7.049M |
| June 30, 2018 | 4.459M |
| March 31, 2018 | 5.164M |
| December 31, 2017 | 5.745M |
| September 30, 2017 | 71.12M |
| June 30, 2017 | 67.57M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | 2.797B |
| Immatics NV | 144.51M |
| Oncolytics Biotech, Inc. | 13.34M |
| Sangamo Therapeutics, Inc. | 78.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 183.23M |
| Shareholders Equity (Quarterly) | 163.68M |
| Debt to Equity Ratio | 0.0056 |
| Current Ratio | 7.263 |
| Net Debt Paydown Yield | -0.01% |